Covance gets into lab management; CuriRx lands National Cancer Institute deal;

> Covance ($COV) is now offering lab management services, aiding its clients in vetting, selecting and overseeing external labs during development. News

> CRO CuriRx landed a 5-year deal with the National Cancer Institute to develop and produce dose forms for studies. Item

> WCCT Global has launched a mobile-phone-friendly patient recruitment system. More

Suggested Articles

Genesis Drug Discovery & Development has bought up New England Discovery Partners as it looks to boost its synthetic and medicinal chemistry.

Sanofi plans to incorporate its real-world data platform with Aetion’s analytics system to better develop studies for regulatory decision-making.

Major CRO player Pharmaceutical Product Development is set to go back on the public markets after announcing its IPO plans.